HIKAL
Back to All Ratios
|
HIKAL Last 5 Year Sales/Fixed Asset History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sales/Fixed Asset(x) | 1.06 | 1.37 | 1.54 | 1.57 | 1.49 |
What is the latest Sales/Fixed Asset ratio of HIKAL ?
Year | Sales/Fixed Asset |
---|---|
Mar2024 | 1.06 |
Mar2023 | 1.37 |
Mar2022 | 1.54 |
Mar2021 | 1.57 |
Mar2020 | 1.49 |
How is Sales/Fixed Asset of HIKAL Trending?
Years | Sales/Fixed Asset | % Change | |
---|---|---|---|
Mar2024 | 1.06 | -22.63 | |
Mar2023 | 1.37 | -11.04 | |
Mar2022 | 1.54 | -1.91 | |
Mar2021 | 1.57 | 5.37 | |
Mar2020 | 1.49 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Sales/Fixed Asset ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹5,119.4 Cr | -0.2% | 10.7% | 50.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,948.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,873.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹116,809.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,963.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,173.2 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -0.2% |
10.7% |
50.2% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses